Washington Trust’s Exelixis EXEL Stock Holding History

Washington Trust’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2,800	Closed	-$93.2K	–	798
2024 Q4	$93.2K	Hold	2,800	–	–	﹤0.01%	352
2024 Q3	$72.7K	Hold	2,800	–	–	﹤0.01%	393
2024 Q2	$62.9K	Hold	2,800	–	–	﹤0.01%	414
2024 Q1	$66.4K	Hold	2,800	–	–	﹤0.01%	417
2023 Q4	$67.2K	Hold	2,800	–	–	﹤0.01%	384
2023 Q3	$61.2K	Hold	2,800	–	–	﹤0.01%	362
2023 Q2	$53.5K	Hold	2,800	–	–	﹤0.01%	408
2023 Q1	$54.3K	Hold	2,800	–	–	﹤0.01%	402
2022 Q4	$44.9K	Hold	2,800	–	–	﹤0.01%	415
2022 Q3	$44K	Hold	2,800	–	–	﹤0.01%	411
2022 Q2	$58K	Hold	2,800	–	–	﹤0.01%	377
2022 Q1	$63K	Hold	2,800	–	–	﹤0.01%	389
2021 Q4	$51K	Hold	2,800	–	–	﹤0.01%	435
2021 Q3	$59K	Hold	2,800	–	–	﹤0.01%	495
2021 Q2	$51K	Hold	2,800	–	–	﹤0.01%	510
2021 Q1	$63K	Hold	2,800	–	–	﹤0.01%	460
2020 Q4	$56K	Hold	2,800	–	–	﹤0.01%	468
2020 Q3	$68K	Hold	2,800	–	–	﹤0.01%	391
2020 Q2	$64K	Hold	2,800	–	–	﹤0.01%	353
2020 Q1	$48K	Buy	+2,800	New	+$51.2K	﹤0.01%	393
2018 Q3	–	Sell	-2,800	Closed	-$60K	–	424
2018 Q2	$60K	Buy	+2,800	New	+$57.9K	﹤0.01%	387

Other funds holding EXEL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Washington Trust's EXEL Position: Q1 2025 in Review

Washington Trust sold out of Exelixis (EXEL) in Q1 2025, closing a stake of 2,800 shares — an estimated $93.2K sold.

Washington Trust first reported a position in EXEL in Q2 2018 and held it in 21 quarters. The position peaked at $93.2K in Q4 2024. 557 funds tracked by Wall St. Rank hold EXEL as of Q1 2025.

Washington Trust reported no remaining Exelixis position as of Q1 2025 after selling out during the quarter.
Washington Trust sold 2,800 Exelixis shares in Q1 2025, an estimated $93.2K.
Washington Trust first reported a position in Exelixis in Q2 2018 and held it in 21 quarters.
Washington Trust's Exelixis position peaked at $93.2K in Q4 2024.
557 funds tracked by Wall St. Rank held Exelixis as of Q1 2025.

Based on Washington Trust's 13F filing for Q1 2025, filed 25 Apr 2025.